acrolein has been researched along with nvp-aew541 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, KH; Henderson, CJ; MacLeod, AK; McLaughlin, LA; McMahon, M; Wolf, CR | 1 |
1 other study(ies) available for acrolein and nvp-aew541
Article | Year |
---|---|
HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents.
Topics: Acrolein; Antineoplastic Agents; Antioxidant Response Elements; Cell Line, Tumor; Cytotoxins; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Neoplasms; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-pim-1; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction | 2014 |